MedTrace Logo

POA Prospective Repository

NCT03324841 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2020-01-27

No results posted yet for this study

Summary

This repository is a multi-center, outcomes study designed to collect data on the demographics, presentation, diagnosis, treatment, cost of associated care, quality of life, and outcomes of subjects utilizing Caris Molecular Intelligence® (CMI) Services for the treatment of cancer.

Conditions

Interventions

DIAGNOSTIC_TEST

Caris MI Profiling

Customized comprehensive biomarker testing

Sponsors & Collaborators

  • Caris Science, Inc.

    lead INDUSTRY

Principal Investigators

  • W. Michael Korn, MD · Caris Life Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-07
Primary Completion
2023-01-01
Completion
2023-01-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03324841 on ClinicalTrials.gov